First Drug for Guillain-Barré Shows Success in Trials

A groundbreaking treatment for Guillain-Barré syndrome has shown remarkable results in late-stage trials, offering hope for the first targeted therapy for this sudden autoimmune condition.

Patients recovered faster and more completely than ever before.